China’s BioKangtai Begins First Shipment of AstraZeneca’s COVID-19 Shot – Community News
Covid-19

China’s BioKangtai Begins First Shipment of AstraZeneca’s COVID-19 Shot

A doctor displays vials of AstraZeneca’s COVID-19 vaccine in his primary care practice as the spread of the coronavirus disease (COVID-19) continues, in Vienna, Austria, May 13, 2021. REUTERS/Leonhard Foeger/File Photo

Register now for FREE unlimited access to reuters.com

BEIJING, Nov 18 (Reuters) – AstraZeneca Plc’s (AZN.L) COVID-19 vaccine partner in China, Shenzhen Kangtai Biological Products (BioKangtai) (300601.SZ), has started the first shipment of the injection and sent more than four million doses to Indonesia, BioKangtai said Friday.

Including the first batch, BioKangtai plans to ship more than eight million doses of the China-made AstraZeneca shot, branded as KconecaVac, to Indonesia this month, said Zhang Qian, general manager of BioKangtai’s international affairs division. in a video interview with local media.

BioKangtai has the right to manufacture the vaccine and the right to sell it in mainland China, Indonesia and Pakistan.

Register now for FREE unlimited access to reuters.com

The shot has not yet begun clinical trials in China, which AstraZeneca hoped to start last year before applying for local regulatory approval for the shot.

Shenzhen-based BioKangtai, which has its own COVID-19 vaccine approved by China, has not said why trials for the AstraZeneca injection have been postponed.

Western companies, including AstraZeneca and BioNTech, are working with Chinese companies to bring their injections to the country, but China has not allowed the use of foreign-developed and approved coronavirus vaccines.

BioKangtai said in February that its facility dedicated to making the AstraZeneca injection is expected to reach an annual production capacity of 400 million doses. The actual production rate remains unclear.

According to the Indonesian Ministry of Health, AstraZeneca already shipped about 10 million doses of its COVID-19 vaccine to Indonesia in October. The Southeast Asian country has also received the vaccine through the COVAX global vaccination program.

Register now for FREE unlimited access to reuters.com

Reporting by Roxanne Liu and Ryan Woo Additional reporting by Stanley Widianto in Jakarta Editing by Mark Potter

Our Standards: The Thomson Reuters Trust Principles.